Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Akakura

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Journal of Molecular Cell Biology|May 8, 2012
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppressionYoshito Hirata, Koichiro Akakura, Celestia S Higano, et al.
Urolithiasis|March 23, 2021
Patients' poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stonesMika Kino, Takumi Hayashi, Daichi Hino, et al.
Case Reports in Urology|July 9, 2019
Alfa-Fetoprotein-Producing Female Primary Urethral Adenocarcinoma with Neuroendocrine DifferentiationTakao Natsuyama, Yozo Mitsui, Masato Uetani, et al.
The Journal of Urology|January 10, 2004
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapySatoko Kojima, Hiroyoshi Suzuki, Koichiro Akakura, et al.
The Journal of Urology|January 17, 2002
Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancerShinzou Isshiki, Koichiro Akakura, Akira Komiya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 1, 2014
Visceral fat accumulation is a risk factor for urinary stoneMasaaki Fujimura, Shinichi Sakamoto, Nobuyuki Sekita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2003
Annual changes of the incidence and clinical characteristics of magnesium ammonium phosphate urinary stonesTakahide Ogata, Koichiro Akakura, Ken-Ichi Mizoguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractionsTohru Okada, Hiroshi Tsuji, Tadashi Kamada, et al.
European Urology|July 12, 2005
Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patientsTetsuro Sasaki, Akira Komiya, Hiroyoshi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Urethral leiomyoma expressing estrogen receptorsTomonori Kato, Takashi Kobayashi, Ryoichi Ikeda, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Journal of Molecular Cell Biology|May 8, 2012
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppressionYoshito Hirata, Koichiro Akakura, Celestia S Higano, et al.
Urolithiasis|March 23, 2021
Patients' poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stonesMika Kino, Takumi Hayashi, Daichi Hino, et al.
Case Reports in Urology|July 9, 2019
Alfa-Fetoprotein-Producing Female Primary Urethral Adenocarcinoma with Neuroendocrine DifferentiationTakao Natsuyama, Yozo Mitsui, Masato Uetani, et al.
The Journal of Urology|January 10, 2004
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapySatoko Kojima, Hiroyoshi Suzuki, Koichiro Akakura, et al.
The Journal of Urology|January 17, 2002
Chromogranin a concentration as a serum marker to predict prognosis after endocrine therapy for prostate cancerShinzou Isshiki, Koichiro Akakura, Akira Komiya, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 1, 2014
Visceral fat accumulation is a risk factor for urinary stoneMasaaki Fujimura, Shinichi Sakamoto, Nobuyuki Sekita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 22, 2003
Annual changes of the incidence and clinical characteristics of magnesium ammonium phosphate urinary stonesTakahide Ogata, Koichiro Akakura, Ken-Ichi Mizoguchi, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2012
Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractionsTohru Okada, Hiroshi Tsuji, Tadashi Kamada, et al.
European Urology|July 12, 2005
Changes in chromogranin a serum levels during endocrine therapy in metastatic prostate cancer patientsTetsuro Sasaki, Akira Komiya, Hiroyoshi Suzuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Urethral leiomyoma expressing estrogen receptorsTomonori Kato, Takashi Kobayashi, Ryoichi Ikeda, et al.
Pageof 12